Correlation Between Microbot Medical and Western Acquisition

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Microbot Medical and Western Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microbot Medical and Western Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microbot Medical and Western Acquisition Ventures, you can compare the effects of market volatilities on Microbot Medical and Western Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microbot Medical with a short position of Western Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microbot Medical and Western Acquisition.

Diversification Opportunities for Microbot Medical and Western Acquisition

0.54
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Microbot and Western is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Microbot Medical and Western Acquisition Ventures in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Western Acquisition and Microbot Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microbot Medical are associated (or correlated) with Western Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Western Acquisition has no effect on the direction of Microbot Medical i.e., Microbot Medical and Western Acquisition go up and down completely randomly.

Pair Corralation between Microbot Medical and Western Acquisition

Given the investment horizon of 90 days Microbot Medical is expected to under-perform the Western Acquisition. In addition to that, Microbot Medical is 1.93 times more volatile than Western Acquisition Ventures. It trades about -0.07 of its total potential returns per unit of risk. Western Acquisition Ventures is currently generating about -0.01 per unit of volatility. If you would invest  1,131  in Western Acquisition Ventures on September 1, 2024 and sell it today you would lose (39.00) from holding Western Acquisition Ventures or give up 3.45% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Microbot Medical  vs.  Western Acquisition Ventures

 Performance 
       Timeline  
Microbot Medical 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Microbot Medical are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Microbot Medical unveiled solid returns over the last few months and may actually be approaching a breakup point.
Western Acquisition 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Western Acquisition Ventures are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Western Acquisition is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Microbot Medical and Western Acquisition Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Microbot Medical and Western Acquisition

The main advantage of trading using opposite Microbot Medical and Western Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microbot Medical position performs unexpectedly, Western Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Western Acquisition will offset losses from the drop in Western Acquisition's long position.
The idea behind Microbot Medical and Western Acquisition Ventures pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance